Dr Reddys Laboratories (RDY) Retained Earnings (2010 - 2026)

Dr Reddys Laboratories (RDY) has reported Retained Earnings for 10 consecutive years, with $42.0 million the latest figure, recorded in Q1 2026.

• Quarterly Retained Earnings fell 98.86% year-over-year to $42.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.0 million (down 98.86% YoY) and the FY2026 annual result came in at $42.0 million, down 98.86% from the prior year.
• Retained Earnings slipped to $42.0 million in Q1 2026 per RDY's latest filing, from $3.7 billion in the prior quarter.
• Over the last five years, Retained Earnings for RDY reached as high as $3.7 billion in Q1 2025 and fell as low as $28.0 million in Q1 2024.
• A 5-year average of $1.3 billion and a median of $45.0 million in 2022 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings plunged 98.93% — and 2025, when it soared 13103.57%.
• Year by year, Retained Earnings stood at $45.0 million in 2022, then soared by 5728.89% to $2.6 billion in 2023, then tumbled by 98.93% to $28.0 million in 2024, then surged by 13103.57% to $3.7 billion in 2025, then slumped by 98.86% to $42.0 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $42.0 million, $3.7 billion, and $28.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.